| 4/02
Clinical Results for Thornton Periodontal Floss (THORNTON) and related
topics
To: Dental Professionals, Patients,
and other interested parties
From: Chairman Thomas Thornton
We have been receiving many favorable reports from
dental professionals in the United States and abroad on the effectiveness
of our Thornton
Periodontal Floss ( hereinafter referred to as THORNTON. These
dental professionals including Dentists, Hygienists, Periodontists,
and others requested that we sponsor a clinical study to test and
quantify the efficacy of THORNTON. We started work on such a study
18 months ago.
We were fortunate to have two Harvard trained clinical
investigators manage the study at Columbia University , School of
Dental and Oral Surgery, Division of Oral Biology.
Objective of Study
The primary purpose of this study was to evaluate the ability of
Thornton
Periodontal Floss (THORNTON) to remove interproximal plaque
and improve gingival health.
Results
In a five week test period THORNTON was shown to significantly
reduce gingival (gum) inflammation.
|
Figure 1: Gingival Index
We at Thornton International notice the curve
is trending lower with time which suggests even lower inflammation
levels can be acheived with regular usage. To test this possibility
we are sponsoring another study in Europe starting later this
year. Results will be available in approximately two years.
The Gingival Index above used Silness-Loe methodolgy which
is considered to be "gold standard" in this field of study.
We are also pleased to announce the The American Dental Association
has allowed us to add the following statement to our 3in1
Floss. "Thornton
3in1 Floss is Accepted as an effective cleansing device
which reduces gingivitis as part of a program for good oral
hygiene to supplement the regular professional care required
of oral health". Council on Scientific Affairs, ADA. |
|
Figure 2: Plaque Index
THORNTON demonstrated a significant decrease
in plaque index over the five week study. |
|
Figure 3: Gingival
Crevicular Fluid Volume
No significant change in GCF volume occurred
over the study period. GCF volume did not correlate with clinical
gingival inflammation as measured by the gingival index. The
sampling methodology used, the limited scale of the Periotron,
and the wide intersubject variations may have accounted for
the findings. |
|
Study Design
This is a single group split mouth longitudinal study design enrolling
29 systemically healthy adult subjects with minimal periodontal
disease. All subjects had their maxillary Canines, first and second
pre-molars and first maxillary molar teeth. All sites had probing
depths of 5mm or less. Subjects received a thorough scaling root
planing within two weeks prior to their entry into the study. At
the baseline visit, all subjects were instructed on the use of Thornton
Periodontal Floss. Each subject was their own control with one
side of the maxilla using the Thornton
Periodontal Floss. Each subject used Thornton
Periodontal Floss once a day. The side using Thornton
Periodontal Floss was determined randomly.
The subject's method
and frequency of toothbrushing was not altered. Each patient was
examined at baseline, one week, two weeks, three weeks, four weeks
and five weeks. The examiner was blinded as to which side was Thornton
Periodontal Floss. The examination consisted of: a) a measurement
of gingival crevicular fluid (GCF) volume in a thirty second sample;
b) a determination of gingival index (GI) (Silness-Loe); and c)
plaque index (PI) (modified Quigley-Hein). Determinations were made
at each of the following tooth surfaces on the maxilla: Mesial surface
of the maxillary first molar, mesial and distal buccal aspect of
the above tooth surfaces by a methylcellulose filter paper strip.
Volume was determined on a calibrated Periotron 8000. For each time
period, GCF volume, GI and PI from each site were averaged for each
subject.
Summary
Thornton
Periodontal Floss (THORNTON) was effective in removing dental
plaque and improving gingival health in the interproximal areas. |
